Pharmacological evaluation of HP 370, a potential atypical antipsychotic agent: 2. In vitro profile
- 1 January 1987
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 11 (3-4), 169-175
- https://doi.org/10.1002/ddr.430110304
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Pharmacological evaluation of HP 370, a potential atypical antipsychotic agent: 1. In vivo profileDrug Development Research, 1987
- SCH 23390 dissociated from conventional neuroleptics in apomorphine climbing and primate acute dyskinesia modelsLife Sciences, 1985
- Decreased antistereotypic effect of neuroleptics after additional treatment with a benzodiazepine, a GABA agonist or an anticholinergic compoundLife Sciences, 1979
- NET UPTAKE OF L‐GLUTAMATE AND GABA BY HIGH AFFINITY SYNAPTOSOMAL TRANSPORT SYSTEMSJournal of Neurochemistry, 1978
- Benzodiazepine receptors: labeling in intact animals with [3H] flunitrazepamEuropean Journal of Pharmacology, 1978
- Inhibition by Neuroleptics of Uptake of 3H-GABA into Rat Brain SynaptosomesActa Pharmacologica et Toxicologica, 1978
- Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brainNeuropharmacology, 1977
- STRUCTURE ACTIVITY RELATIONS FOR THE INHIBITION OF 5‐HT UPTAKE INTO RAT HYPOTHALAMIC HOMOGENATES BY SEROTONIN AND TRYPTAMINE ANALOGUESJournal of Neurochemistry, 1973
- Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic systemJournal of Pharmacy and Pharmacology, 1973
- Dopamine turnover in the corpus striatum and the limbic system after treatment with neuroleptic and anti-acetylcholine drugsJournal of Pharmacy and Pharmacology, 1972